Macromolecular inhibitors of malarial cysteine proteases —An invited review - Journal of Biomedical Science and Engineering

JBiSE > Vol.6 No.9, September 2013

Journal of Biomedical Science and Engineering

Volume 6, Issue 9 (September 2013)

ISSN Print: 1937-6871 ISSN Online: 1937-688X

Google-based Impact Factor: 0.66 Citations h5-index & Ranking

Macromolecular inhibitors of malarial cysteine proteases —An invited review ()

HTML XML

Download as PDF (Size: 1515KB) PP. 885-895

DOI: 10.4236/jbise.2013.69108 4,878 Downloads 7,249 Views Citations

Author(s)

Kailash C. Pandey

Affiliation(s)

Host-Parasite Interaction Biology Group, Protein-Protein Interaction Unit, National Institute of Malaria Research, (ICMR) Sector-8, Dwarka, India.

ABSTRACT

There are evidences indicating that cysteine proteases play an essential role in malaria parasites; therefore, an obvious area of investigation is the inhibition of these enzymes to treat malaria. Small cysteine protease inhibitors of malaria are well studied, but macromolecular nature of inhibitor is a new field to explore. In malarial cysteine proteases, there are macromolecular endogenous inhibitors playing important roles in regulation of the cysteine protease activity of parasite and host. Recent studies suggested that there are known and characterized endogenous inhibitors like falstatin present in P. falciparum, PbICP (inhibitor of cysteine protease in P. berghei), PyICP (inhibitor of cysteine protease in P. yoelli), and other macromolecular inhibitors which are the prodomain of enzyme itself regulating the activity of the mature enzyme. All the known macromolecular endogenous inhibitors are using specific loop-like structure to interact with malarial cysteine proteases. The majority of macromolecular inhibitors are competitive in nature, and block access to the active site of their target protease, but do not bind in a strictly substrate-like manner. They rather interact with the protease subsites and catalytic residues in a non-catalytically competent manner. In future, designing inhibitors based on these protein-protein interactions will be a new approach in the field of malaria. Since macromolecular inhibitors can gain potency through the burial of a large surface area and specificity through contacts with secondary binding sites critical for inhibition, and could be less prone to drug resistant mutation.

KEYWORDS

Malaria; Cysteine Protease; Hemoglobinase; Macromolecular Inhibitor; Protein-Protein Interaction

Share and Cite:

Pandey, K. (2013) Macromolecular inhibitors of malarial cysteine proteases —An invited review. Journal of Biomedical Science and Engineering, 6, 885-895. doi: 10.4236/jbise.2013.69108.

Cited by

[1]	Effect of cysteine protease inhibitor (E64) on haematological changes of New Zealand rabbits experimentally infected with Trypanosoma brucei brucei
	2019

[2]	Molecular targets for malarial chemotherapy: a review
	2019

[3]	Synthetic microbial consortia enable rapid assembly of pure translation machinery
	Nature Chemical Biology, 2018

[4]	Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery
	Current Drug Targets, 2018

[5]	Control of malaria by bio-therapeutics and drug delivery systems
	2017

[6]	Targeting cysteine proteases from Plasmodium falciparum: A general overview, rational drug design and computational approaches for drug discovery.
	2016

[7]	New Targets in Malaria Parasite Chemotherapy: A Review
	Malaria Control & Elimination, 2015

[8]	Molecular and immunological characterisation of proteins from Anisakis pegreffii and their immune stimulatory effect on the human health system
	2015

[9]	Malaria Control & Elimination
	2015

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies